Heartflow is a medical technology company advancing the diagnosis and management of coronary artery disease, the #1 cause of death worldwide, using cutting-edge technology. The flagship product—an AI-driven, non-invasive cardiac test supported by the ACC/AHA Chest Pain Guidelines called the Heartflow FFRCT Analysis—provides a color-coded, 3D model of a patient’s coronary arteries indicating the impact blockages have on blood flow to the heart. Heartflow is the first AI-driven non-invasive integrated heart care solution across the CCTA pathway that helps clinicians identify stenoses in the coronary arteries (RoadMap™Analysis), assess coronary blood flow (FFRCT Analysis), and characterize and quantify coronary atherosclerosis (Plaque Analysis). Our pipeline of products is growing and so is our team; join us in helping to revolutionize precision heartcare.
Heartflow is a VC-backed company that has received international recognition for exceptional strides in healthcare innovation, is supported by medical societies around the world, cleared for use in the US, UK, Europe, Japan and Canada, and has been used for more than 400,000 patients worldwide.
The Vice President of Health Economics and Market Access Strategy will lead the development and execution of comprehensive strategies to secure coding, coverage, and payment for Heartflow’s future portfolio of products and services aimed at the early diagnosis of individuals at risk for coronary artery disease. In collaboration with the SVP of Market Access and Reimbursement, this role is responsible for both strategic and operational aspects of market access, including direct engagement with providers, professional societies, government and commercial payers, and other key stakeholders.
Job Responsibilities:
Skills Needed:
Educational Requirements & Work Experience:
This position has an estimated base salary of $250,000 - $320,000, a cash bonus and stock options.
NEVER ENDING TRAVELS
Hubs
Compugen Inc
Rackspace Technology
CrowdStrike